APA

Shiffman M. L., Cheinquer H., Berg C. P., Berg T., de Figueiredo-Mendes C., Dore G. J., Ferraz M. L., Mendes-Corrêa M. C., Lima M. P., Parise E. R., Rios A. M. P., Reuter T., Sanyal A. J., Shafran S. D., Hohmann M., Tatsch F., Bakalos G. & Zeuzem S. (20150728). Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial. : Hepatology international.

Chicago

Shiffman Mitchell L, Cheinquer Hugo, Berg Christoph P, Berg Thomas, de Figueiredo-Mendes Cláudio, Dore Gregory J, Ferraz Maria Lúcia, Mendes-Corrêa Maria Cássia, Lima Maria Patelli, Parise Edison R, Rios Alma Minerva Perez, Reuter Tania, Sanyal Arun J, Shafran Stephen D, Hohmann Marc, Tatsch Fernando, Bakalos George and Zeuzem Stefan. 20150728. Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial. : Hepatology international.

Harvard

Shiffman M. L., Cheinquer H., Berg C. P., Berg T., de Figueiredo-Mendes C., Dore G. J., Ferraz M. L., Mendes-Corrêa M. C., Lima M. P., Parise E. R., Rios A. M. P., Reuter T., Sanyal A. J., Shafran S. D., Hohmann M., Tatsch F., Bakalos G. and Zeuzem S. (20150728). Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial. : Hepatology international.

MLA

Shiffman Mitchell L, Cheinquer Hugo, Berg Christoph P, Berg Thomas, de Figueiredo-Mendes Cláudio, Dore Gregory J, Ferraz Maria Lúcia, Mendes-Corrêa Maria Cássia, Lima Maria Patelli, Parise Edison R, Rios Alma Minerva Perez, Reuter Tania, Sanyal Arun J, Shafran Stephen D, Hohmann Marc, Tatsch Fernando, Bakalos George and Zeuzem Stefan. Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial. : Hepatology international. 20150728.